Rain Therapeutics Clinical Trials
A clinical trial is a controlled study where an experimental drug or device is tested in humans. The purpose of a clinical trial is to evaluate the safety and efficacy (how well it works) of an experimental drug or device. To participate in a clinical trial, you must meet all eligibility criteria and be willing to following the directions of the study doctor.
Rain is currently conducting a Phase 2 clinical trial studying tarloxotinib (Tarlox) in non-small cell lung cancer (NSCLC) patients with EGFR Exon 20 or HER2-activating mutations and other advanced solid tumors with NRG1/ERBB family gene fusions. To learn more about NSCLC, EGFR/HER2 mutations, NRG1/ERBB fusions, Tarlox and details about the clinical trial, continue reading below. If you have any additional questions, you can contact the study center in your area.